Alembic Pharmaceuticals Limited secures final USFDA approval for key diabetes therapy Generic version of Farxiga opens door to 180-day exclusivity...
Read moreFinal approval for 12.5 mg extended-release tablets expands psychiatric care offerings Drug deemed equivalent to Paxil CR for multiple mental...
Read moreTotal Triumph: Entire PGP-FABM batch secures placements; 45 students set to join firms by mid-2026 Sector Surge: Recruiters span agri-tech,...
Read moreRising burden of atopic dermatitis in Indian children sparks urgent call for early intervention Kenvue India and IAP Bengaluru unite...
Read more₹50-crore acquisition of Velbiom Probiotics Pvt. Ltd.’s Rx portfolio signals aggressive push into next-gen gut science Strategic fit to turbocharge...
Read more‘Noveltreat’ & ‘Sematrinity’ aim to expand access to advanced GLP-1 therapy Weekly treatment costs slashed, making global-standard care more affordable...
Read moreGame-changing weekly semaglutide therapy launched at unprecedented affordability ‘SUNDAE’ aims to bring advanced GLP-1 treatment within reach of 70% of...
Read moreR ARIVANANTHAM CHENNAI, MAR 12 The 10th edition of CAHOCON 2026, India’s flagship conference on healthcare quality and patient safety,...
Read moreChief Guest Sunaina Tomar and other dignitaries light the auspicious lamp. - NE photo Udgam Trust’s...
Read moreAlembic Pharmaceuticals Limited marks entry into the US branded drug market with successful commercial rollout Pivya® (pivmecillinam) positioned as a...
Read moreEmail:
ne.gowri1964@gmail.com
Phone:
9643255068
Editorial and Administrative Office:
Block No 1 Flat No 4C
Wipro Street, Sholinganallur
Off Old Mabalipuram Road
Chennai 600119, Tamil nadu
96, First Floor, Srinathnagar Society,
(Landmark: Near Panchdev Mandir,
Karmacharinagar Vibhag-I),
Ghatlodia, Ahmedabad-380 061
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com